1. Home
  2. VNDA
  3. VNDA News

Latest Vanda Pharmaceuticals Inc. (VNDA) News on December 22, 2024

VNDA

MT Newswires

2 days ago

Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera
VNDA

PR Newswire

2 days ago

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

Exploring Three High Growth Tech Stocks In The United States
VNDA

Simply Wall St.

2 days ago

Exploring Three High Growth Tech Stocks In The United States

US Penny Stocks To Watch In December 2024
VNDA

Simply Wall St.

4 days ago

US Penny Stocks To Watch In December 2024

New Strong Buy Stocks for November 14th
VNDA

Zacks

a month ago

New Strong Buy Stocks for November 14th

Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
VNDA

PR Newswire

a month ago

Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences

Vanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ...
VNDA

GuruFocus.com

a month ago

Vanda Pharmaceuticals Inc (VNDA) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising ...

VNDA

Associated Press Finance

2 months ago

Vanda: Q3 Earnings Snapshot

Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results
VNDA

PR Newswire

2 months ago

Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks
VNDA

Simply Wall St.

2 months ago

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
VNDA

Benzinga

2 months ago

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

Health Care Roundup: Market Talk
VNDA

The Wall Street Journal

2 months ago

Health Care Roundup: Market Talk

Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024
VNDA

PR Newswire

2 months ago

Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024

Biotech Stock Roundup: VNDA, JAZZ Up on Updates, NVAX Suffers Setback & More
VNDA

Zacks

2 months ago

Biotech Stock Roundup: VNDA, JAZZ Up on Updates, NVAX Suffers Setback & More

VNDA Rejects Second Takeover Bid by Cycle Group, Stock Rises
VNDA

Zacks

2 months ago

VNDA Rejects Second Takeover Bid by Cycle Group, Stock Rises

Cycle Pharmaceuticals reaffirms proposal to acquire Vanda Pharmaceuticals
VNDA

TipRanks

2 months ago

Cycle Pharmaceuticals reaffirms proposal to acquire Vanda Pharmaceuticals

VNDA

MT Newswires

2 months ago

Vanda Pharmaceuticals Shares Rise; Cycle Pharmaceuticals' Buyout Offer Rejected Again

Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.
VNDA

PR Newswire

2 months ago

Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.

Vanda Pharmaceuticals rejects Cycle Pharma's second takeover offer
VNDA

Reuters

2 months ago

Vanda Pharmaceuticals rejects Cycle Pharma's second takeover offer

Cycle Pharma Is Said to Stand By $488 Million Offer for Vanda
VNDA

Bloomberg

2 months ago

Cycle Pharma Is Said to Stand By $488 Million Offer for Vanda

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
VNDA

Zacks

3 months ago

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
VNDA

Zacks

3 months ago

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis

Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
VNDA

BioPharma Dive

3 months ago

Novo sinks on obesity drug results; Sanofi reveals anticipated MS data

FDA declines approval of Vanda’s gastroparesis treatment
VNDA

Pharmaceutical Technology

3 months ago

FDA declines approval of Vanda’s gastroparesis treatment

Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today
VNDA

Motley Fool

3 months ago

Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today

VNDA

MT Newswires

3 months ago

Vanda Pharma Shares Fall 15% as FDA Denies Approval of Tradipitant NDA for Treating Gastroparesis Symptoms

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
VNDA

PR Newswire

3 months ago

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference
VNDA

PR Newswire

3 months ago

Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
VNDA

PR Newswire

4 months ago

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference
VNDA

PR Newswire

4 months ago

Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference

VNDA

Thomson Reuters StreetEvents

5 months ago

Q2 2024 Vanda Pharmaceuticals Inc Earnings Call

VNDA

Associated Press Finance

5 months ago

Vanda: Q2 Earnings Snapshot

Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results
VNDA

PR Newswire

5 months ago

Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
VNDA

PR Newswire

5 months ago

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

VNDA

MT Newswires

6 months ago

Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex
VNDA

PR Newswire

6 months ago

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
VNDA

BioPharma Dive

6 months ago

Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders
VNDA

PR Newswire

6 months ago

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders

VNDA

MT Newswires

6 months ago

Sector Update: Health Care Stocks Ease Late Afternoon

VNDA

MT Newswires

6 months ago

Sector Update: Health Care Stocks Softer Thursday Afternoon

VNDA

MT Newswires

6 months ago

Sector Update: Health Care

VNDA

MT Newswires

6 months ago

Vanda Pharmaceuticals Receives Revised Offer From Future Pak; Shares Rise

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
VNDA

PR Newswire

6 months ago

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
VNDA

Pharmaceutical Technology

6 months ago

Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m

Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?
VNDA

Zacks

6 months ago

Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?

VNDA

MT Newswires

7 months ago

Sector Update: Health Care Stocks Higher in Late Afternoon Trading

VNDA

MT Newswires

7 months ago

Sector Update: Health Care Stocks Advance Thursday Afternoon

VNDA

MT Newswires

7 months ago

Sector Update: Health Care

VNDA

MT Newswires

7 months ago

Vanda Pharmaceuticals' Shares Rally After Company Receives $466 Million Buyout Offer From Cycle Pharma

Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.

VNDA

MT Newswires

7 months ago

Cycle Pharmaceuticals Offers to Buy Vanda Pharmaceuticals for $466 Million

VNDA

MT Newswires

7 months ago

Top Premarket Gainers

VNDA

MT Newswires

7 months ago

Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference

Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®

Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Announces Presentations at SLEEP 2024

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
VNDA

Zacks

7 months ago

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Vanda Pharmaceuticals reports positive data from motion sickness trial
VNDA

Clinical Trials Arena

7 months ago

Vanda Pharmaceuticals reports positive data from motion sickness trial

VNDA

MT Newswires

7 months ago

Vanda Pharmaceuticals Says Second Phase 3 Study of Tradipitant in Motion Sickness Yields 'Positive' Results

Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness

Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
VNDA

GuruFocus.com

7 months ago

Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
VNDA

Insider Monkey

7 months ago

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript

VNDA

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Vanda Pharmaceuticals Inc Earnings Call

VNDA

GuruFocus.com

7 months ago

Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

VNDA

Associated Press Finance

7 months ago

Vanda: Q1 Earnings Snapshot

Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results

VNDA

MT Newswires

7 months ago

Vanda Pharmaceuticals Shares Rise After Future Pak Adds $260 Million Potential Payments to Cash Offer

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
VNDA

PR Newswire

7 months ago

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

VNDA

Reuters

7 months ago

UPDATE 3-Future Pak sweetens take-private offer for Vanda Pharmaceuticals

VNDA

Reuters

7 months ago

Future Pak increases buyout offer for Vanda Pharmaceuticals

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
VNDA

PR Newswire

8 months ago

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024

VNDA

Reuters

8 months ago

UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer

VNDA

Reuters

8 months ago

Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer

VNDA

GlobeNewswire

8 months ago

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
VNDA

Zacks

8 months ago

Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know

Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
VNDA

Zacks

8 months ago

Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
VNDA

PR Newswire

8 months ago

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation

VNDA

MT Newswires

8 months ago

Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court

VNDA

Reuters

8 months ago

UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
VNDA

Reuters

8 months ago

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

VNDA

Reuters

8 months ago

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

VNDA

Reuters

8 months ago

Butler Hall Capital urges Vanda to engage in sales discussions

Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up
VNDA

Zacks

8 months ago

Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up

Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know
VNDA

Zacks

8 months ago

Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
VNDA

Benzinga

8 months ago

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share

Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
VNDA

Motley Fool

8 months ago

Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
VNDA

PR Newswire

8 months ago

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

VNDA

Reuters

8 months ago

Vanda Pharmaceuticals rejects takeover proposal from Future Pak

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
VNDA

PR Newswire

8 months ago

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors
VNDA

Zacks

8 months ago

Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors

Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
VNDA

Zacks

8 months ago

Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
VNDA

Zacks

8 months ago

AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors

Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?
VNDA

Zacks

9 months ago

Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?

Vanda (VNDA) Up on FDA Nod for Fanapt in Bipolar I Disorder
VNDA

Zacks

9 months ago

Vanda (VNDA) Up on FDA Nod for Fanapt in Bipolar I Disorder

Here's Why Amgen (AMGN) Stock is Outperforming the Industry
VNDA

Zacks

9 months ago

Here's Why Amgen (AMGN) Stock is Outperforming the Industry

Why Is Vanda Pharmaceuticals Stock Trading Higher Today?
VNDA

Benzinga

9 months ago

Why Is Vanda Pharmaceuticals Stock Trading Higher Today?

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
VNDA

PR Newswire

9 months ago

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance
VNDA

Zacks

9 months ago

AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance

AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
VNDA

Zacks

9 months ago

AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod

Share on Social Networks: